Saturday 17 October 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024. In the quarter to June 2026, revenue grew 24.1%, EPS grew 39.1% and free cash flow grew 40.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

316.58 13.42 −4.07%

Follow KRYS

Alert me

Market cap: $9.8B
P/E: 38.3×
Fwd P/E: 38.6×
Dividend yield: —
F-score: 7/9
Altman Z: 39.03
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	44.94	33.33	34.82	25.62	+8 more quarters Free account
P/S ratio Full definition →	24.92	18.13	18.34	13.70
P/FCF ratio Full definition →	42.57	31.87	37.69	30.79
P/Operating CF Full definition →	146.75	94.12	92.07	128.88
P/B ratio Full definition →	8.08	5.93	5.85	4.49
Price to Tangible BV Full definition →	8.08	5.93	5.85	4.49
EV/Sales Full definition →	23.00	16.16	16.21	11.74
EV/EBITDA Full definition →	49.55	36.37	37.58	26.58
EV/Operating CF Full definition →	37.19	26.94	31.40	24.86
EV/FCF Full definition →	39.29	28.40	33.31	26.38
Quick Ratio Full definition →	7.73	8.82	9.28	9.43
Current Ratio Full definition →	8.32	9.46	9.95	10.14
Net Debt/EBITDA Full definition →	(14.10)	(14.86)	(17.98)	(17.01)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.33	0.34	0.33	0.34
Operating CF/Net income Full definition →	1.37	1.44	1.51	0.50
Capex/Depreciation Full definition →	(2.28)	(4.14)	(1.21)	(1.06)
Research and Development Expense of Revenue Full definition →	12.18%	13.18%	13.81%	14.91%
Selling, General and Administrative Expense of Revenue Full definition →	33.43%	35.25%	38.70%	38.42%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	11.87%	11.70%	12.85%	13.45%
Graham Net Nets Full definition →	0.08	0.12	0.13	0.16
Graham Number Full definition →	92.54	87.19	81.93	78.06
Earnings Yield Full definition →	2.23%	3.00%	2.87%	3.90%
Free Cash Flow Yield Full definition →	2.35%	3.14%	2.65%	3.25%
Revenue per Share Full definition →	4.04	3.97	3.70	3.38
Operating CF per Share Full definition →	2.53	2.74	2.68	1.37
Capex per Share Full definition →	(0.12)	(0.24)	(0.07)	(0.06)
Free Cash Flow per Share Full definition →	2.41	2.50	2.60	1.31
Cash per Share Full definition →	28.64	28.11	28.60	25.25
Shareholders Equity per Share Full definition →	46.03	43.59	42.14	39.30
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	46.03	43.59	42.14	39.30
Free Cash Flow Full definition →	71.22	73.23	75.37	37.96
Working Capital Full definition →	932.25	911.94	921.66	834.38
Capital Expenditures Full definition →	(3.56)	(7.15)	(2.14)	(1.70)
Net Current Asset Value Full definition →	918.13	899.50	910.37	823.43
EV/EBIT Full definition →	51.22	37.72	39.11	27.65
Capex to Sales Full definition →	0.03	0.06	0.02	0.02
Price to Operating Income Full definition →	55.50	42.33	44.24	32.26
Other line items
Average Receivables Full definition →	125.05	115.14	116.09	113.47
Average Payables Full definition →	6.83	3.38	4.11	3.84
Average Inventory Full definition →	38.30	36.29	33.49	28.11
Average Assets Full definition →	1,319.52	1,235.69	1,194.82	1,111.21
Average Common Equity Full definition →	1,199.89	1,130.70	1,082.97	1,011.86

Show all line items

Columns are period end dates

Stockrow Weekly